These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
8. Caenorhabditis elegans ortholog of a diabetes susceptibility locus: oga-1 (O-GlcNAcase) knockout impacts O-GlcNAc cycling, metabolism, and dauer. Forsythe ME; Love DC; Lazarus BD; Kim EJ; Prinz WA; Ashwell G; Krause MW; Hanover JA Proc Natl Acad Sci U S A; 2006 Aug; 103(32):11952-7. PubMed ID: 16882729 [TBL] [Abstract][Full Text] [Related]
9. Intracellular protein glycosylation modulates insulin mediated lifespan in C.elegans. Rahman MM; Stuchlick O; El-Karim EG; Stuart R; Kipreos ET; Wells L Aging (Albany NY); 2010 Oct; 2(10):678-90. PubMed ID: 20952811 [TBL] [Abstract][Full Text] [Related]
10. O-GlcNAcylation, a sweet link to the pathology of diseases. Nie H; Yi W J Zhejiang Univ Sci B; 2019 May; 20(5):437-448. PubMed ID: 31090269 [TBL] [Abstract][Full Text] [Related]
11. O-GlcNAc cycling: implications for neurodegenerative disorders. Lazarus BD; Love DC; Hanover JA Int J Biochem Cell Biol; 2009 Nov; 41(11):2134-46. PubMed ID: 19782947 [TBL] [Abstract][Full Text] [Related]
12. Role of Chatham JC; Zhang J; Wende AR Physiol Rev; 2021 Apr; 101(2):427-493. PubMed ID: 32730113 [TBL] [Abstract][Full Text] [Related]
13. Regulating the Regulators: Mechanisms of Substrate Selection of the O-GlcNAc Cycling Enzymes OGT and OGA. Stephen HM; Adams TM; Wells L Glycobiology; 2021 Aug; 31(7):724-733. PubMed ID: 33498085 [TBL] [Abstract][Full Text] [Related]
14. Cross-talk between GlcNAcylation and phosphorylation: roles in insulin resistance and glucose toxicity. Copeland RJ; Bullen JW; Hart GW Am J Physiol Endocrinol Metab; 2008 Jul; 295(1):E17-28. PubMed ID: 18445751 [TBL] [Abstract][Full Text] [Related]
15. The hexosamine signaling pathway: deciphering the "O-GlcNAc code". Love DC; Hanover JA Sci STKE; 2005 Nov; 2005(312):re13. PubMed ID: 16317114 [TBL] [Abstract][Full Text] [Related]
16. Molecular Interrogation to Crack the Case of O-GlcNAc. Estevez A; Zhu D; Blankenship C; Jiang J Chemistry; 2020 Sep; 26(53):12086-12100. PubMed ID: 32207184 [TBL] [Abstract][Full Text] [Related]
17. The non-catalytic domains of O-GlcNAc cycling enzymes present new opportunities for function-specific control. Hu CW; Wang K; Jiang J Curr Opin Chem Biol; 2024 Aug; 81():102476. PubMed ID: 38861851 [TBL] [Abstract][Full Text] [Related]
18. The intersections between O-GlcNAcylation and phosphorylation: implications for multiple signaling pathways. Zeidan Q; Hart GW J Cell Sci; 2010 Jan; 123(Pt 1):13-22. PubMed ID: 20016062 [TBL] [Abstract][Full Text] [Related]
19. Transcriptional regulation of Qian K; Wang S; Fu M; Zhou J; Singh JP; Li MD; Yang Y; Zhang K; Wu J; Nie Y; Ruan HB; Yang X J Biol Chem; 2018 Sep; 293(36):13989-14000. PubMed ID: 30037904 [TBL] [Abstract][Full Text] [Related]
20. A mitotic GlcNAcylation/phosphorylation signaling complex alters the posttranslational state of the cytoskeletal protein vimentin. Slawson C; Lakshmanan T; Knapp S; Hart GW Mol Biol Cell; 2008 Oct; 19(10):4130-40. PubMed ID: 18653473 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]